New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 12, 2013
08:10 EDTSNTISenesco to provide update on Phase 1b/2a trial at hematology meeting
Senesco Technologies announced that it will make two presentations on its gene regulation technology for blood-borne cancer care at the 55th American Society of Hematology Annual Meeting and Exposition to be held from December 7-10. The abstracts are available on the ASH website, Senesco said.
News For SNTI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SNTI

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use